Program Spotlight

Third year Cancer Prevention Fellow, Dr. Kate Elfer, was accepted into The Sallie Rosen Kaplan (SRK) Postdoctoral Fellowship for Women Scientists’ 2022 cohort. The SRK fellowship is a highly competitive, unpaid, annual, one-year program that provides additional mentoring opportunities, networking, seminars, and workshops to help prepare NCI’s female and non-binary postdoctoral fellows for the competitive nature of the job market and help them to transition to independent research careers.
As someone who never had a non-male research mentor, Dr. Elfer is extremely grateful that the program has connected her with Dr. Romina Goldszmid (Earl Stadtman Investigator, CCR), a secondary mentor who she hopes can help her navigate some of the issues unique to being a woman in a male dominated field. Dr. Elfer remains thankful to her primary preceptor, Dr. Brandon Gallas (FDA/CDRH/OSEL/DIDSR), for giving her the time and space to grow as a researcher by applying to the SRK program.

The SRK program’s goal to assist women and nonbinary postdocs on their path to independence was particularly meaningful to Dr. Elfer, who saw this program as an opportunity to ready herself for her transition to an independent research career. “Over the last year, I have established my research projects and what training and resources are available to me as a Cancer Prevention and Interagency Oncology Task Force fellow. I believe the SRK helps complete my training experience as a CPFP fellow by focusing on the “soft-skills” needed for success: emotional intelligence, leadership, self-reflection, goal identification, and building a support network. The SRK program provides the mentorship, the coaching, and the skills to achieve my dream of becoming a leader in STEM education.”

The 2022 cohort consists of twelve highly impressive women researchers, all sharing the common experiences of having confidence, drive, and passion impacted negatively solely based on their gender. Dr. Elfer believes the program is already helping them build up the skills and resources within themselves to fulfill their dreams.

To learn more about the 30-week SRK Fellowship, visit Cancer Training at the NCI.

The annual NCI Director’s Awards recognize exceptional individual and group performance or special efforts in support of NCI’s biomedical research mission. This year at the NCI Director’s Awards ceremony hosted on February 14, 2022, Cancer Prevention Fellows, Drs. Derek Brown, Alexandra Budenz, Ian Buller, Michelle Doose, Sydney O’Connor, Heather Platter, Esmeralda Ramírez-Peña, Naoise Synnott, and Jacqueline B. Vo were honored with NCI Director’s Emerging Leader Awards. This achievement was well-earned through their leadership of the Cancer Prevention Fellowship Program’s (CPFP) Fellows Advisory Board (FAB) during the first year of the COVID-19 pandemic.

This FAB leadership group was nominated by CPFP’s Learning & Development Specialist, Ms. Ann Maxson, and CPFP’s Director, Dr. Lisa Signorello, for spearheading innovative opportunities for fellows to develop skills and community during the COVID-19 pandemic. In April 2020, as the NIH community transitioned to remote work due to the COVID-19 pandemic, this group of emerging leaders swiftly and selflessly volunteered to serve in leadership roles on the FAB. They were quick to recognize the potential impacts of the COVID-19 pandemic on their fellow colleagues and to ramp up activities to serve them. They developed strategic programming for building virtual community and advocating for the needs of the fellows, for advancing the fellows’ scientific and professional development, and for promoting their professional networking. In these efforts, they cumulatively hosted dozens of innovative events that aimed to offset and ease the pandemic’s effects on fellows. They served as exemplary role models as they motivated and empowered NCI trainees to achieve and connect during a time of great uncertainty. Their empathy, vision, and commitment to their colleagues was a true demonstration of their outstanding leadership abilities.

The National Cancer Institute (NCI) has a commitment to improving diversity, equity and inclusion within NCI and in the wider cancer research workforce. The Diversity Career Development Program (DCDP), established by the Intramural Diversity Workforce Branch (IDWB) within the Center for Cancer Training (CCT), brings us closer to that goal. This competitive program aims to provide NCI postdoctoral trainees with the tools necessary to develop as leaders in independent research careers through a yearlong mentoring program. The CPFP is pleased to announce that two of our fellows, Drs. Brittany Lord and Waruiru Mburu have been selected to be among this year’s 12 DCDP’s participants. Both Dr. Lord’s and Dr. Mburu’s interests and career goals make them an exceptional selection for this program.

Dr. Lord’s postdoctoral work includes investigations into population-level differences in genetic ancestry and their association with breast and prostate cancer prognosis and survival. She looks forward to her participation in the DCDP as she believes the program will help her set attainable goals as an independent researcher, encourage creating strong collaborative networks, and empower her to have difficult conversations around the topic of racism and inclusivity. Following her postdoctoral training, Dr. Lord plans to apply her experience in basic science and epidemiology into her own integrative cancer health disparities research program at a U.S.-based academic institution. She feels that the DCDP will provide her with unique leadership and professional development skills that will bolster her skillset and improve her ability to perform impactful health disparities research.

Dr. Mburu is unwavering in her dedication to eliminating cancer disparities in sub-Saharan Africa (SSA). As a Kenya native, Dr. Mburu has a personal connection and strong motivation in addressing health inequities in her home country and beyond. In preparation, she has honed her skills in study design, data analysis and evidence dissemination to different stakeholders. From her past research on tuberculosis and malaria in East Africa to her collaboration with breast cancer stakeholders in Ghana, Dr. Mburu has already begun to make an impact. She has identified the DCDP as an opportunity to build confidence as a leader and build community at NCI. She believes these two key pieces will jolt her career and assist in fulfilling her mission of addressing health disparities in her community.

The DCDP is part of the NCI Equity and Inclusion Program. NCI’s commitment to equity and inclusion aligns with the NIH UNITE initiative, an NIH-wide goal to address structural racism within the scientific community. For more information on the DCDP, visit here.

Dr. Holli Loomans-Kropp, a fourth-year Cancer Prevention Fellow working in the Gastrointestinal and Other Cancers Branch of the Division of Cancer Prevention, has been appointed to serve on the American Gastroenterological Association (AGA) Trainee and Early Career Committee. The AGA Trainee and Early Career Committee is a 12-member committee that works to enhance the value of AGA membership and career development opportunities for early-career GI scientists. Dr. Loomans-Kropp will occupy the sole seat on the committee reserved for a postdoctoral fellow for a two-year term that formally begins in June 2021.

It was while researching additional leadership and training opportunities outside of NIH that Dr. Loomans-Kropp came across the AGA Trainee and Early Career Committee and decided to apply. She had been participating in other AGA-sponsored activities and events (e.g., Digestive Disease Week) since her graduate school days training in cancer biology at Vanderbilt and found this Committee’s responsibilities especially appealing. Having held positions related to career development, she is excited to be contributing to the “development of educational programs that will be useful to trainees during their fellowship”, in addition to “working with other committees within AGA to better serve the training needs of early-career members.” Personally, she is hoping to gain additional collaborative and leadership skills, as well as build a diverse network of colleagues in similar fields.

Dr. Loomans-Kropp became a member of the AGA in 2017 – the same year that she entered the CPFP. She stated that this international association, founded in 1897, is “a great organization that bridges gastroenterological clinical work and research. Because of my interest in translational research, AGA provides a prime opportunity to stay on top of the advances in gastroenterology, particularly gastrointestinal cancers.” And, for those fellows whose interests lie in gastrointestinal diseases and cancer, she recommends the AGA as “a great way to stay in the know of the hot topics and clinical trials in the field."

Cancer Prevention Fellows (CPFs), all working in the Division of Cancer Epidemiology and Genetics (DCEG), are among the 2021 recipients of the prestigious William G. Coleman, Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award. Established in 2016 by the National Institute on Minority Health and Health Disparities, this competitive award program has been designed to support innovative research concepts and ideas with the potential for high impact in any area of minority health and health disparities research. Recipients receive $15,000 to study key determinants of health inequities and advance scientific knowledge within the field for their 1-year projects. This year, two separate projects led by CFPs won an award:

Dr. Cody Ramin submitted her winning proposal entitled “Endogenous Hormones and Ultrasound Tomography Measures of Breast Density by Race in a Longitudinal Study of Women Undergoing Tamoxifen Therapy.” Dr. Ramin conducts her research in both the Radiation Epidemiology Branch (REB) and the Integrative Tumor Epidemiology Branch (ITEB). Dr. Ramin will examine the association between circulating endogenous hormones and changes in breast density prior to and after tamoxifen initiation among Black and White women. In addition to providing etiological insights on breast cancer, she believes that the results could inform targeted approaches for risk reduction and understanding of racial disparities in breast cancer survival.

Drs. Jacqueline Vo, Naoise Synnott, Ian Buller, and Derek Brown submitted their winning collaborative proposal entitled “HDoCS in PLCO: Health Disparities of Cancer Survivors in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.” Dr. Vo conducts her research in REB, Dr. Synnott in ITEB, Dr. Buller in the Occupational and Environmental Epidemiology Branch (OEEB), and Dr. Brown in ITEB. The team cites a lack of research on how lower individual- and population-level socioeconomic status and genetic ancestry affect cancer survivorship. The study aims to bridge this gap by exploring health disparities related to individual- and population-level socioeconomic factors (e.g., income, education, rurality) and genetic ancestry and their relationship with all-cause and cancer-specific mortality among cancer survivors. Once completed, they envision their research could benefit underserved cancer survivors and inform tailored interventions.